Equity (Tables)

9 Months Ended

Sep. 30, 2017

Equity [Abstract]

Schedule of Common Stock Granted

During the nine months ended September 30, 2017 and 2016, the Company granted common shares to certain employees as follows:

	Nine Months ended September 30,
	2017	2016
Performance Shares(1)
Shares granted:
Index - 1Q	106,706	404,466
Peer - 1Q	106,705	404,463
Index - 2Q	163,466	—
Peer - 2Q	163,463	—
Grant date fair value per share:(2)
Index - 1Q	$6.82	$4.53
Peer - 1Q	$6.34	$4.58
Index - 2Q	$4.05	—
Peer - 2Q	$4.27	—
Non-Vested Common Shares:(3)
Shares issued	237,560	225,090
Grant date fair value	$2,551	$1,724

(1) The shares vest based on the Company's total shareholder return growth after a three-year measurement period relative to an index and a group of Company peers. Dividends will not be paid on these grants until earned. Once the performance criteria are met and the actual number of shares earned is determined, such shares vest immediately. The 2Q shares were subject to shareholder approval, which was obtained in May 2017.

(2) The fair value of grants was determined at the grant date using a Monte Carlo simulation model.

(3) The shares vest ratably over a three-year service period.

Schedule of Accumulated Other Comprehensive Income (Loss)

A summary of the changes in accumulated other comprehensive income (loss) related to the Company's cash flow hedges is as follows:

	Nine Months ended September 30,
	2017			2016
Balance at beginning of period	$	(1,033	)	$	(1,939	)
Other comprehensive income (loss) before reclassifications	581			(6,035		)
Amounts of loss reclassified from accumulated other comprehensive income to interest expense	962			3,091
Balance at end of period	$	510		$	(4,883	)